81 – 90 of 329
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Epidemiological aspects of inhibitor development in hemophilia and strategies of management
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.
(
- Contribution to journal › Article
-
Mark
The ageing patient with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Evaluation of Algorithms for the Treatment of Problem Bleeding Episodes in Patients With Hemophilia Having Inhibitors.
(
- Contribution to journal › Article
-
Mark
Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A.
(
- Contribution to journal › Letter
-
Mark
Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.
(
- Contribution to journal › Article
-
Mark
Targeting Factor Replacement Therapy in Severe Hemophilia: Which Level Is Important?
(
- Contribution to journal › Article
-
Mark
Introduction.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Thrombin stimulates insulin secretion via protease-activated receptor-3.
(
- Contribution to journal › Article
-
Mark
Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophilia.
(
- Contribution to journal › Article